They chose a yeast called Saccharomyces boulardii, which has been proven to be safe and well-tolerated in IBD patients, has anti-inflammatory properties, and can withstand antibiotic use.
The BioPYM platform utilizes synthetic biology to create disease-targeting yeast Saccharomyces boulardii. Wild-type S. boulardii has known probiotic properties and is widely available in drug ...